Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.

Eliza B GeerRoberto SalvatoriAtanaska ElenkovaMaria FleseriuRosario PivonelloPrzemyslaw WitekRichard A FeeldersMarie BexStina W BorresenSoraya PuglisiBeverly M K BillerFredric CohenFrancesca Pecori Giraldi

Published in: Pituitary (2020)

Treatment with levoketoconazole was associated with sustained, meaningful improvements in QoL, depression, and certain clinical signs and symptoms characteristic of CS. ClinialTrials.gov identifier: NCT01838551.

Keyphrases

patient reported outcomes
sleep quality
depressive symptoms
case report
combination therapy